These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
733 related items for PubMed ID: 22857879
1. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. Jia G, Erickson RW, Choy DF, Mosesova S, Wu LC, Solberg OD, Shikotra A, Carter R, Audusseau S, Hamid Q, Bradding P, Fahy JV, Woodruff PG, Harris JM, Arron JR, Bronchoscopic Exploratory Research Study of Biomarkers in Corticosteroid-refractory Asthma (BOBCAT) Study Group. J Allergy Clin Immunol; 2012 Sep; 130(3):647-654.e10. PubMed ID: 22857879 [Abstract] [Full Text] [Related]
2. Serum periostin levels serve as a biomarker for both eosinophilic airway inflammation and fixed airflow limitation in well-controlled asthmatics. Takahashi K, Meguro K, Kawashima H, Kashiwakuma D, Kagami SI, Ohta S, Ono J, Izuhara K, Iwamoto I. J Asthma; 2019 Mar; 56(3):236-243. PubMed ID: 29648484 [Abstract] [Full Text] [Related]
3. External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma. Wagener AH, de Nijs SB, Lutter R, Sousa AR, Weersink EJ, Bel EH, Sterk PJ. Thorax; 2015 Feb; 70(2):115-20. PubMed ID: 25422384 [Abstract] [Full Text] [Related]
12. Can we predict sputum eosinophilia from clinical assessment in patients referred to an adult asthma clinic? Yap E, Chua WM, Jayaram L, Zeng I, Vandal AC, Garrett J. Intern Med J; 2013 Jan; 43(1):46-52. PubMed ID: 21790924 [Abstract] [Full Text] [Related]
13. Decreased epithelial and sputum miR-221-3p associates with airway eosinophilic inflammation and CXCL17 expression in asthma. Zhang K, Liang Y, Feng Y, Wu W, Zhang H, He J, Hu Q, Zhao J, Xu Y, Liu Z, Zhen G. Am J Physiol Lung Cell Mol Physiol; 2018 Aug 01; 315(2):L253-L264. PubMed ID: 29644894 [Abstract] [Full Text] [Related]
14. Serum Periostin as a Biomarker for Comorbid Chronic Rhinosinusitis in Patients with Asthma. Asano T, Kanemitsu Y, Takemura M, Yokota M, Fukumitsu K, Takeda N, Ichikawa H, Uemura T, Takakuwa O, Ohkubo H, Maeno K, Ito Y, Oguri T, Maki Y, Ono J, Ohta S, Nakamura Y, Izuhara K, Suzuki M, Niimi A. Ann Am Thorac Soc; 2017 May 01; 14(5):667-675. PubMed ID: 28248547 [Abstract] [Full Text] [Related]
16. Utility of serum periostin in combination with exhaled nitric oxide in the management of asthma. Nagasaki T, Matsumoto H, Izuhara K, KiHAC Respiratory Medicine Group. Allergol Int; 2017 Jul 01; 66(3):404-410. PubMed ID: 28256388 [Abstract] [Full Text] [Related]
17. Biomarkers for differentiation of patients with asthma and chronic obstructive pulmonary disease. Katoh S, Ikeda M, Shirai R, Abe M, Ohue Y, Kobashi Y, Oka M. J Asthma; 2018 Oct 01; 55(10):1052-1058. PubMed ID: 29035604 [Abstract] [Full Text] [Related]
19. Periostin, type 2 biomarker, is not associated with asthma control grade in asthmatic allergic children. Licari A, Brambilla I, Sacchi L, Marseglia G, Ciprandi G. Respir Med; 2019 May 01; 151():118-120. PubMed ID: 31047107 [Abstract] [Full Text] [Related]